Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of meet
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the exchanges that its management will meet investors, fund managers, and analysts at the Nuvama Specialty Chemicals and Healthcare conference scheduled for 25th June 2025 in Mumbai. The intimation is filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The letter is signed by Manisha Saraf, Company Secretary. No new financial or business information has been disclosed; the filing is purely a pre-meeting schedule announcement as required by listing rules.
This is a routine regulatory disclosure with no material financial impact. Investors may watch for any post-meeting insights or presentations, but the stock is unlikely to react meaningfully to the announcement itself.